Table 1 Characteristics of clinical trials included in the meta-analysis
Study and Treatment arm | Trial | Male (%) | Mean Age(y) | Etiology HBV/HCV | Cirrhosis | Child-Pugh A/B | Albumin (g/L) |
|---|---|---|---|---|---|---|---|
Lee (Cancer 1997) | P | ||||||
TACE(n=31) | 84 | 52 | 29/2 | NA | NA | 37 | |
Conservative(n=16) | 81 | 51 | 13/2 | NA | NA | 36 | |
Luo (Ann Surg Oncol 2011) | P | ||||||
TACE(n=84) | 98 | 45 | 78/- | 42 | NA | 41 | |
Conservative(n=80) | 91 | 47 | 70/- | 35 | NA | 41 | |
Niu (Med Oncol 2011) | P | ||||||
TACE(n=115) | 93 | 46 | 106/- | NA | 88/27 | 37 | |
Conservative(n=35) | 94 | 48 | 31/- | NA | 21/14 | 36 | |
Chung (Radiology 2011) | R | ||||||
TACE(n=83) | 89 | 55 | 71/4 | 63 | 57/26 | 36 | |
Conservative(n=42) | 71 | 58 | 31/2 | 34 | 15/27 | 33 | |
KM Kim (JGH 2009) | R | ||||||
TACE(n=149) | 87 | 52 | NA | NA | 106/41 | NA | |
TACI(n=53) | 77 | 54 | NA | NA | 23/29 | NA | |
Hepatic resection (n=19) | 95 | 50 | NA | NA | 17/2 | NA | |
Conservative(n=60) | 90 | 53 | NA | NA | 18/33 | NA | |
Zhou (APJCP 2011) | R | ||||||
TACE(n=10) | 100 | NA | 12/- | 10 | 5/5 | NA | |
LT(n=12) | 100 | NA | 10/- | 9 | 4/6 | NA | |
Hepatic resection (n=69)* | 96 | NA | 66/- | 63 | 55/14 | NA | |
Conservative(n=30) | 87 | NA | 26/- | 23 | 9/11 | NA | |
JH Kim (APT 2009) | R | ||||||
TACE(n=49) | 90 | 54 | 37/2 | 36 | 30/17 | NA | |
TACI(n=61) | 87 | 54 | 56/1 | 45 | 22/32 | NA | |
Peng (Cancer 2012) | R | ||||||
TACE(n=402) | 93 | 55 | 356/7 | 363 | 389/13 | 34 | |
Hepatic resection (n=201) | 93 | 55 | 172/4 | 176 | 197/4 | 37 |